Skip to: Content
Skip to: Site Navigation
Skip to: Search

July 25, 2008 4:12:53 PM CDT



FDA Given New Muscle To Monitor Drugs

Posted May 10, 07 5:41 AM CDT in US Politics Business Science & Health 

(Newser) – The Food and Drug Administration would be given sweeping new powers to order drug recalls, regulate advertising and mandate changes in labels under a bill passed by the Senate yesterday. The bill signals a fundamental shift in the FDA's role, the New York Times reports, requiring the agency to track drugs after, as well as before, approval.

The bill—prompted by the outcry over Vioxx, the FDA-approved painkiller that turned out to cause heart attacks—is expected to be signed into law. The only no vote came from Vermont independent Bernard Sanders, who says he is “extremely disappointed” the drug companies won their battle to prevent imports of cheaper drugs from Canada.

Source New York Times

0 comments | Print E-mail | Digg Seed this on Newsvine Add this link to Del.icio.us StumbleUpon
  (Associated Press)
« Prev« Prev | Next »Next » Slideshow
Our editors also recommend:

Strengthening the FDA

Threads (1 of 4)

Tags

drugs   FDA   safety   recall   drug companies   Vioxx



Loading...

Loading...

Today's Most Popular


Other Home Stories

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »